ClinConnect ClinConnect Logo
Search / Trial NCT02281721

Surpass Flow Diverter for Intracranial Aneurysms: SURMOUNT Registry Data Collection

Launched by STRYKER NEUROVASCULAR · Oct 31, 2014

Trial Information

Current as of June 04, 2025

Terminated

Keywords

ClinConnect Summary

This will be a prospective, observational, multi-center, single-arm, post-marketing, international registry with consecutive enrollment of a minimum of 150 patients treated with the Surpass Flow Diverter in accordance with the standard of care at up to 30 registry sites.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients who are to be treated with a Surpass Flow Diverter(s) will be eligible to participate in this registry. Patients will be enrolled on a consecutive basis.
  • Exclusion Criteria:
  • This is a standard of care registry. Patients should be excluded if standard of care at a given site is such that they are not eligible for treatment with a Surpass Flow Diverter(s).

About Stryker Neurovascular

Stryker Neurovascular is a leading medical technology company focused on developing innovative solutions for the treatment of neurovascular conditions. As a subsidiary of Stryker Corporation, it specializes in advanced products and therapies aimed at improving patient outcomes in the fields of stroke intervention and surgical treatment of neurovascular diseases. With a commitment to research and development, Stryker Neurovascular works collaboratively with healthcare professionals to deliver cutting-edge technologies that enhance procedural efficiency and safety, ultimately striving to transform the standard of care in neurovascular medicine.

Locations

Barcelona, , Spain

Santander, , Spain

Genova, , Italy

Kortrijk, , Belgium

Kassel, , Germany

Birmingham, , United Kingdom

Mannheim, , Germany

Besançon, , France

Nijmegen, Gelderland, Netherlands

Helsinki, , Finland

Turku, , Finland

Le Kremlin Bicêtre, , France

Paris, , France

Tours, , France

Freiburg, , Germany

Treviso, , Italy

Stockholm, , Sweden

Romford, Essex, United Kingdom

Liverpool, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Patrick A Brouwer, MD

Principal Investigator

Karolinska Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials